Bentham Science Publishers
Bentham Science Publishers is a major publisher of more than 100 peer-reviewed science, technology and medical (STM) journals, along with a rapidly growing collection of eBooks. Since 1993, Bentham Science Publishers has been catering to the information needs of the pharmaceutical, engineering, biomedical and medical research community.501 - 520 of 1957 results
-
-
Current Chinese Science
More LessCurrent Chinese Science publishes original research articles, letters, case reports, reviews/mini-reviews and guest edited thematic issues in various disciplines focused largely on science in China, while contributions from abroad are also welcome. Current Chinese Science is not limited to a specific field but instead covers all major fields of science, technology, and medicine.
-
-
-
Current Clinical Pharmacology
More LessCurrent Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: pharmacokinetics; therapeutic trials; adverse drug reactions; drug interactions; drug metabolism; pharmacoepidemiology; and drug development. The journal is essential reading for all researchers in clinical pharmacology.
-
-
-
Current Computer - Aided Drug Design
(Advances in Artificial Intelligence)
More LessCurrent Computer-Aided Drug Design (CCADD) is an interdisciplinary journal (or theme/initiative) dedicated to publishing high-quality research at the intersection of computational chemistry, artificial intelligence, and pharmaceutical sciences. The journal aims to accelerate drug discovery by integrating traditional computer-aided drug design (CADD) techniques with cutting-edge artificial intelligence-driven drug design (AIDD) methodologies.
Topics of interest include, but are not limited to:- AI/ML algorithms for hit identification, optimization, and target prediction
- Deep learning, generative models for de novo drug design
- Multi-omics integration, pharmacogenomics and AI for target identification
- AI-enhanced molecular dynamics and binding free energy calculations
- Structure- and ligand-based drug design
- AI-assisted repurposing of existing drugs and natural products
-
-
-
Current Computer Science
More LessCurrent Computer Science publishes original research articles, letters, reviews/mini-reviews, and guest-edited thematic issues dealing with various topics related to Computer Science.
Current Computer Science is not limited to a specific aspect of the field but is instead devoted to a wide range of sub-fields in the field. Articles of an interdisciplinary nature are particularly welcome. Submissions in the following areas are of special interest to the readers of this journal:- Artificial Intelligence
- Communication and Security
- Computational Science and Numerical Methods
- Computer Architecture and Organization
- Computer Engineering
- Computer Ethics
- Computer Graphics and Multimedia
- Computer Networks
- Computer Vision
- Cybersecurity and Cryptography
- Data Management and Data Mining
- Evolutionary Computing/Quantum Computing
- Human-Computer Interaction
- Machine Learning
- Operating Systems
- Programming Paradigms and Languages
- Relational Databases
- Software Engineering
- Telecommunications Engineering
- Theoretical Computer Science
-
-
-
Current Cosmetic Science
More Less“Current Cosmetic Science” publishes original research articles, in-depth reviews/mini reviews, thematic issues, and technical notes covering all aspects of advancements in fundamental and applied research on skin, cosmetic and cosmeceutical products, isolation and comprehensive characterization of natural products and their synthesis to the beneficial effects of the constituents as cosmetic and cosmeceutical ingredients. The journal also explicitly welcomes interdisciplinary contributions considering wider social, cultural, ethical and applied aspects of cosmetic science in modern society.
General subject areas include but not limited to:- Cosmetic material research and characterization
- Cosmetic and Cosmeceutical formulation development
- Characterization and evaluations
- In vitro and in vivo safety in humans
- Efficacy of cosmetics and cosmeceuticals
- Toxicological studies in various animal models
- Topical products intended for Skin, nails and hair
- Analytical techniques involved in cosmetic and cosmeceutical product formulations and analysis
- Cosmetic Surgery and Dentistry
- Skin physiology and pharmacology
- Aesthetic and rejuvenation research
- Topical and transdermal testing
- Physical chemistry and technology of emulsion and dispersed systems, theory and application of surfactants
- Olfactory research
- Antioxidants
- Natural products
-
-
-
Current Dentistry
More LessCurrent Dentistry, a peer-reviewed journal, publishes original research, expert reviews, and thematic issues in all areas of dental, oral and craniofacial sciences including biological, clinical, materials engineering and bioengineering aspects of dental research. The journal will be of interest to researchers in dental, oral, hard-tissue, and craniofacial science.
-
-
-
Current Developments in the Detection and Control of Multi Drug Resistance
More LessThe rise in the incidence of infections is caused by multi drug resistant (MDR) bacteria, it is essential to elucidate the basic mechanism of antibiotic resistance to discover effective methods for diagnosis and treatment of infections.
The use of pathogen-specific probes offers a faster alternative for pathogen detection and could improve the diagnosis of infection. High resolution melting analysis techniques are useful for the detection of multi drug resistant pathogens. Rational Structural Based Drug Design is a common method to identify a lead compound and take it forward for further developments.
This book provides information about recent strategies involved in the diagnosis and treatment of infections caused by MDR bacteria. The volume covers the use of molecular probes for the quantification of pathogenic bacteria, along with other techniques mentioned above.
Chapters also cover the use of identification of novel drug targets from the Lipid A biosynthesis and also from quorum sensing mediated biofilm formation in MDR bacteria. Chapters also cover herbal alternatives for the treatment of MDR bacteria like the use of Cassia aungustifolia in treatment of various diseases. The reference is suitable for biomedical students, cellular and molecular biologists.
-
-
-
Current Diabetes Reviews
More LessCurrent Diabetes Reviews publishes full-length/mini-reviews, original research articles, drug clinical trial studies, and guest-edited issues on all the latest advances in diabetes and its related areas dedicated to clinical research, e.g., pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. It also includes topics related to diabetic complications, such as retinopathy, neuropathy, nephropathy, renal failure and impotence, hypertension, gastrointestinal disorders, hearing impairment, hyperlipidemia, and vascular and coronary heart diseases. Articles related to pancreatic islet dysfunction and insulin resistance, adipose tissue function, and glucose homeostasis are also covered. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.
Current Diabetes Reviews is an international, peer-reviewed journal on all aspects of diabetes, published monthly (print & online) by Bentham Science Publishers.
-
-
-
Current Diagnosis of Infant Tuberculosis Infection
More LessOne of the most extraordinary characteristics of Mycobacterium tuberculosis infection is its capacity to remain within the host's tissues for a long period of time. There is an enormous reservoir of persons latently infected with tuberculosis (LTBI) estimated at about a third of the world's population. From this reservoir arise about 10 million new cases of active TB and more than two million deaths occur annually. Current Diagnosis of Infant Tuberculosis Infection covers problems concerning the diagnosis of LTBI, giving an overview of commercially available options and, unlike most reviews on this subject, also points out some tools currently under development. The Ebook provides comprehensive understandable, practice-oriented information on this subject, while keeping frontier research developments in consideration. It serves as an update to readers from universities to the research center and hospital staff - as well as a guide for helping clinicians to improve their diagnostic skills regarding TB infections in an endemic country (such as Brazil).
-
-
-
Current Drug Abuse Reviews
More LessCurrent Drug Abuse Reviews aims to publish the highest quality reviews, meta-analyses and drug clinical trial studies on all latest advances on alcohol and drug abuse and addiction.
Book reviews are also published. The Journal will further comprise an agenda listing relevant meetings and conferences that will take place in near future, and advertisement.
-
-
-
Current Drug Delivery
More LessCurrent Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trial studies in the rapidly developing field of drug delivery. Modern drug research aims to build the delivery properties of a drug at the design phase; however, in many cases, this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.
The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical, and chemical methods. The drugs include a wide range of bioactive compounds, from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides, and sugars. The journal will also report progress in the fields of transport routes and mechanisms, including efflux proteins and multi-drug resistance.
The journal is essential for all pharmaceutical scientists involved in drug design, development, and delivery.
Current Drug Delivery is an international, peer-reviewed journal on all aspects of drug delivery, published monthly (print & online) by Bentham Science Publishers.
-
-
-
Current Drug Discovery Technologies
More LessDue to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing original research papers, full-length/mini-reviews, drug clinical trial studies, and guest-edited thematic issues describing novel approaches and cutting-edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science, including integration issues of the drug discovery process.
Current Drug Discovery Technologies is an essential journal for all scientists and research managers involved in drug discovery who wish to keep abreast of all the modern techniques and technologies used in drug discovery.
Current Drug Discovery Technologies is an international, peer-reviewed journal on all aspects of technologies involved in drug discovery, published bi-monthly (print & online) by Bentham Science Publishers.
-
-
-
Current Drug Metabolism
More LessCurrent Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini-review articles and guest-edited issues on drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government, and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and, most importantly, drug metabolism.
More specifically, the journal covers in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling, and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; and bioactivation, reactive metabolites, and developments for the identification of drug metabolites. It also includes preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.
Current Drug Metabolism is an international, peer-reviewed journal on all aspects of drug metabolism, published monthly (print & online) by Bentham Science Publishers.
-
-
-
Current Drug Research Reviews
More LessCurrent Drug Research Reviews publishes research articles, full-length/mini review articles and clinical studies on the design and development of new drugs, including drug targeting, medicinal chemistry, in-silico drug design, combinatorial chemistry, meta-analyses, drug abuse and addiction, drug-drug interactions and enzyme kinetics; species scaling and extrapolations; drug transporters; target organ toxicity and inter-individual variability in drug exposure-response; extrahepatic metabolism; bio-activation, reactive metabolites, high-throughput screening, drug targets and structure-activity relationships.
The journal aims to cover the latest developments in all important aspects of drug design, delivery, development and research.
Current Drug Research Reviews is essential for all pharmaceutical scientists involved in drug design and development.
Current Drug Research Reviews is an international, peer-reviewed journal on all aspects of drug design, delivery, development, and research, published quarterly (print & online) by Bentham Science Publishers.
-
-
-
Current Drug Safety
More LessCurrent Drug Safety publishes frontier articles on all the latest advances in drug safety. The journal aims to publish the highest quality research articles, full-length/mini-reviews, and case reports in the field. Topics covered include adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, and post-marketing surveillance. It also includes articles focused on resources for the identification of harmful substances and cellular, biochemical, and molecular mechanisms that are responsible for the side effects of drugs. The journal is essential reading for all researchers and clinicians involved in drug safety.
Current Drug Safety is an international, peer-reviewed journal on all aspects of drug safety, published quarterly (print & online) by Bentham Science Publishers.
-
-
-
Current Drug Targets
More LessCurrent Drug Targets aims to cover the latest and most outstanding developments in medicinal chemistry and pharmacology of molecular drug targets, e.g., disease-specific proteins, receptors, enzymes, and genes.
Current Drug Targets publishes guest-edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts full-length/mini-review articles and drug clinical trial studies for publication.
As the discovery, identification, characterization, and validation of novel human drug targets for drug discovery continue to grow, this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Current Drug Targets is an international, peer-reviewed journal on all aspects of drug targets, published monthly (print & online) by Bentham Science Publishers.
-
